Natalia Alekseevna Shnayder; Aiperi K. Khasanova; Anna Strelnik; Mustafa Al-Zamil; Andrey Otmakhov; Н. Г. Незнанов; German Alexandrovich Shipulin; Марина Михайловна Петрова; Natalia P. Garganeeva; Regina Faritovna Nasyrova

Cyclooxygenase Inhibition Safety and Efficacy in Inflammation-Based Psychiatric Disorders

Molecules 25(22) (2020)

Maria Grazia Perrone; Antonella Centonze; Morena Miciaccia; Savina Ferorelli; Antonio Scilimati

Adjunctive Aspirin vs Placebo in Patients With Schizophrenia: Results of Two Randomized Controlled Trials

Schizophrenia Bulletin 47(4) (2020)

Mark Weiser; Daisy Zamora; Linda W. Levi; Igor Nastas; Ilan Gonen; Paull Radu; Valentin Petre Matei; Anatol Nacu; Larisa Boronin; Michael Davidson; John M. Davis

Circulating microRNA Profiles Identify a Patient Subgroup with High Inflammation and Severe Symptoms in Schizophrenia Experiencing Acute Psychosis

International Journal of Molecular Sciences 25(8) (2024)

Takuya Miyano; Tsuyoshi Mikkaichi; Kouichi Nakamura; Yasushi Yoshigae; Kelly Abernathy; Yuji Ogura; Naoki Kiyosawa

Linking Metabolic Disorders and Immune System Phenomena in Schizophrenia: The Role of Adipose Tissue and Inflammation

Biomedicines 13(9) (2025)

Aleksandra Julia Oracz; Mateusz Zwierz; Maciej Naumowicz; Stefan Modzelewski; Maria Suprunowicz; Napoleon Waszkiewicz

Targeting of inflammation and prostaglandins by nonsteroidal anti-inflammatory drugs in schizophrenia: A narrative review

Psychiatry Research 351 (2025)

Hayder Mutter Al-Kuraishy; Hamdoon Abdelhamid Mohammed; Ghassan Mohammad Sulaiman; Majid Sakhi Jabir; Ali Ismail Al-Gareeb; Ali K. Albuhadily

Antipsychotic Effects of Celecoxib Add-On Haloperidol in Schizophrenia: A Randomized Double-Blind Placebo-Controlled Clinical Trial

Iranian Journal of Psychiatry and Behavioral Sciences 18(1) (2024)

Mehran Zarghami; Nasrin Dodangi; Paria Azari; Alireza Khalilian

Comparing the Effects of Adjunct Aspirin and Simvastatin on Psychopathology Among Inpatients With Schizophrenia

Iranian Rehabilitation Journal 20(1) (2022)

Matina Pourghasem; Gita Sadighi; Arash Mirabzadeh

Efficacy and safety of anti-inflammatory drug-assisted treatment of symptoms in patients with schizophrenia: a meta-analysis

BMC Psychiatry 26(1) (2026)

Honglian Li; Hong Shen; Xueyu Duan; Meixian Guo; Xiaobo Liu

Role of Immunity in Pathogenesis of Psychosis

IntechOpen eBooks (2021)

Wafa Abdelghaffar; Oussama Sidhom; LILIA LAADHAR; R. Rafrafi

Antithrombotic agents in the treatment of severe mental illness: A systematic review and meta-analysis of randomized controlled trials

Neuroscience & Biobehavioral Reviews 183 (2026)

Caroline Fussing Bruun; Mette Ungermann Fredskild; Maria Faurholt‐Jepsen; Maj Vinberg; Lars Vedel Kessing; Klaus Munkholm

OpenAlex

The Role of Inflammation in the Treatment of Schizophrenia

Neuroinflammation in schizophrenia: the role of nuclear factor kappa B

COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders

Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing

Anti-inflammatory medications for the treatment of mental disorders: A scoping review

Peripheral Immune-Inflammatory Pathways in Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: Exploring Their Potential as Treatment Targets

Cytokine Imbalance as a Biomarker of Treatment-Resistant Schizophrenia